Access

News and Views

Nature 452, 707-708 (10 April 2008) | doi:10.1038/452707a; Published online 9 April 2008

Open Innovation Challenges

naturejobs

Neurodegeneration: A question of balance

Leslie Michels Thompson1

Top

When a disease-associated gene is mutated, is the cellular activity of its protein product enhanced or reduced? For at least one neurodegenerative disease, spinocerebellar ataxia 1, the answer seems to be both.

Ten devastating neurodegenerative disorders, including Huntington's disease, that are caused by mutations in unrelated genes have one feature in common: in the disease gene, the CAG nucleotide triplet, which encodes the glutamine amino acid, is repeated many times. Consequently, the resulting protein contains a tract of glutamine residues, and disorders with this feature are known collectively as polyglutamine-repeat diseases1.

  1. Leslie Michels Thompson is in the Departments of Psychiatry and Human Behavior, of Neurobiology and Behavior and of Biological Chemistry, University of California, Irvine, Gillespie 2121, Irvine, California 92696-4260, USA.
    Email: lmthomps@uci.edu

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Polyglutamine neurodegeneration: minding your Ps and Qs

Nature Medicine News and Views (01 Jul 2003)

Polyglutamines, nuclear inclusions and neurodegeneration

Nature Medicine News and Views (01 Nov 1997)

See all 17 matches for News And Views